The story of Viagra, originally marketed by copyright, presents a fascinating case study for backers considering the healthcare arena . Despite its initial success and impact of countless in sales, the exclusivity end has opened the door for alternative medications, substantially eroding profit opportunities. This change raises doubts about the con